ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cellXin Liu, Wenli Feng, Qing Xiao et al.|Cancer Letters|2015Cited by 3
Effects of ABL SH3-T79Y mutant combined with imatinib on the proliferation of chronic myeloid leukemia cellsLiang-xue Wen, Wenli Feng, Xin Liu et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2015Cited by 0